Breast Cancer Recurrence, Early Stage 1, 2, Breast Cancer Test, India

Prognostic Test For Breast Cancer In India

Welcome to OncoStem

At OncoStem, we develop innovative prognostic tests that assess aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. Since 2011, our vision is to empower the doctors with evidence-based treatment plans with our smart prognostic tests. These actionable tests help the physicians in formulating a customized treatment plan by understanding the tumour biology. Robust research is ongoing in our laboratory to develop novel tests for other cancers.

CanAssist Breast

CanAssist Breast is our flagship product which uses a proprietary Artificial Intelligence-based statistical model to identify the patient's risk of breast cancer recurrence over five years. It is a prognostic test that analyses the critical biomarkers in the tumour and classifies the patients into "low- risk" or "high-risk" for cancer recurrence. Based on the risk scores, the oncologists can frame an informed and personalized treatment plan wherein the low-risk patients can safely avoid chemotherapy.

Choose the right treatment with CanAssist Breast by weighing the risks and benefits of chemotherapy.

WHAT WE DO


Breast Cancer Recurrence Test
AI-driven biomarker-based prognostic tests for cancer
Stage 1 Breast Cancer Test
Individualized cancer therapy customized to each patient’s needs
Stage 2 Breast Cancer Test
Personalized treatments to improve quality of life
Early Stage Breast Cancer
First test to be validated on Indian patients
Treatment Of Early Stage Breast Cancer
Trusted by 300+ oncologists across South Asia
Early Stage Breast Cancer Prognosis
"Best Innovation-Risk Assessment" by NASSCOM

ONCOSTEM FEATURES


CANASSIST BREAST

Canassist Prognostic Test For Breast Cancer In India

KNOW MORE ABOUT
BREAST CANCER

Prognostic Test For200 Breast Cancer India
Early Stage Breast Cancer
Canassitbreast Support Programs

SUPPORT PROGRAMS FOR
BREAST CANCER PATIENTS

THE SCIENCE
BEHIND CANASSIST
BREAST

Science of Canassist
Recurrent Breast Cancer Awareness Test
Scientific Publication Oncstem

SCIENTIFIC
PUBLICATIONS

Oncostem Scientific Publications
News Oncostem
News Oncostem

LATEST NEWS
AND EVENTS

ONCOSTEM FEATURES


CANASSIST BREAST

Canassist CanAssist-Breast

THE SCIENCE &
BEHIND CANASSIST
BREAST

Science of Canassist
Science behind Canassist
Scientific Publication Oncostem

SCIENTIFIC
PUBLICATIONS

scientific-publication

KNOW MORE ABOUT
BREAST CANCER

Oncostem Stage 1 Test
Oncostem Blog
Canassitbreast Support Programs

SUPPORT PROGRAMS FOR
BREAST CANCER PATIENTS

Canassist Support
News Oncostem

LATEST NEWS
AND EVENTS

Oncostem News
Oncostem Canassist

LATEST NEWS
AND EVENTS

TESTIMONIALS

What oncologists and cancer patients are saying about CanAssist Breast

My surgical oncologist mentioned CanAssist Breast to me, and I’m so glad she did. My medical oncologist and I had decided to skip chemotherapy, so when this test result also came back low-risk, you can imagine how greatly comforting that was to me.
-Breast Cancer Patient, Chennai

Want to know about your recurrence risk?

to personalize your cancer treatment and reduce the risk & side effects of chemotheraphy